IMS China Forecasts Rapid Growth In China’s Pharmaceutical Market Despite Global Slowdown
This article was originally published in PharmAsia News
Executive Summary
IMS China recently predicted that the global pharmaceutical market will experience a further slowdown this year, and that the source of market growth has shifted from the U.S. and EU to emerging markets. Emerging markets will have huge potential in the next 10 years, contributing one-third of overall growth in the global pharmaceutical industry. China is positioned to be the largest emerging market in the next five years. Last year, the Chinese market increased by 26 percent - the highest rate worldwide - and this year it is expected to expand by more than 20 percent. Many multinational pharmaceutical companies have crafted strategies aimed at raising their investment in the country and at expanding from first-tier urban centers to second- and third-tier cities. (Click here for more - Chinese Language)